Skip to main content
Erschienen in: Virchows Archiv 3/2008

01.03.2008 | Original Article

Consistent numerical chromosome aberrations in thecofibromas of the ovary

verfasst von: Francesca Micci, Lisbeth Haugom, Vera M. Abeler, Claes G. Tropé, Håvard E. Danielsen, Sverre Heim

Erschienen in: Virchows Archiv | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Sex cord-stromal tumors of the ovary comprise 8% of all ovarian neoplasms. Because they consist of cells that resemble embryonic sex cord and/or specialized ovarian stroma cells, their cytologic and histologic features can be viewed as reflecting a continuum from fibromas to thecomas with thecofibromas in between. Existing cytogenetic knowledge about ovarian thecomas–thecofibromas–fibromas is restricted to 44 cases with chromosomal abnormalities. The most common aberration has been trisomy 12, identified either by karyotyping or using fluorescence in situ hybridization (FISH). We wanted to obtain more information about the genomic composition of these tumors, and, therefore, examined 29 new thecoma–thecofibroma–fibroma tumors of the ovary using karyotyping, comparative genomic hybridization, interphase FISH, and DNA ploidy analysis. We detected aneuploidy in 21 tumors. Trisomy and/or tetrasomy 12 was the most common chromosomal aberration, found in 15 tumors (71.5% of the aneuploid tumors or 51.5% of all analyzed tumors), followed by trisomy for chromosomes 10, 18, 4, and 9. Some monosomies (for chromosomes 4, 9, 10, and 18) were also identified, either as the sole change or in combination with trisomies. The nonrandom occurrence of these aneuploidies in these benign tumors strongly indicates that they play a major pathogenetic role, but how trisomies and other aneuploidies contribute to tumorigenesis remains unknown.
Literatur
1.
Zurück zum Zitat Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C (2002) Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol 38:11–21PubMedCrossRef Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C (2002) Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol 38:11–21PubMedCrossRef
2.
Zurück zum Zitat Brandal P, Bjerkehagen B, Heim S (2004) Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 6:578–583PubMedCrossRef Brandal P, Bjerkehagen B, Heim S (2004) Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 6:578–583PubMedCrossRef
3.
Zurück zum Zitat Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM (1991) Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138:515–520PubMed Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM (1991) Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138:515–520PubMed
4.
Zurück zum Zitat Garcia-Marco JA, Price CM, Ellis J, Morey M, Matutes E, Lens D, Colman S, Catovsky D (1996) Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia 10:1705–1711PubMed Garcia-Marco JA, Price CM, Ellis J, Morey M, Matutes E, Lens D, Colman S, Catovsky D (1996) Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia 10:1705–1711PubMed
5.
Zurück zum Zitat Geisler CH, Philip P, Christensen BE, Hou-Jensen K, Pedersen NT, Jensen OM, Thorling K, Andersen E, Birgens HS, Drivsholm A, Ellegaard J, Larsen JK, Plesner T, Brown P, Andersen PK, Hansen MM (1997) In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 21:1011–1023PubMedCrossRef Geisler CH, Philip P, Christensen BE, Hou-Jensen K, Pedersen NT, Jensen OM, Thorling K, Andersen E, Birgens HS, Drivsholm A, Ellegaard J, Larsen JK, Plesner T, Brown P, Andersen PK, Hansen MM (1997) In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 21:1011–1023PubMedCrossRef
6.
Zurück zum Zitat Shaffer LG, Tommerup N (eds) (2005) An international system for human cytogenetic nomenclature. Karger S, Basel Shaffer LG, Tommerup N (eds) (2005) An international system for human cytogenetic nomenclature. Karger S, Basel
7.
Zurück zum Zitat Izutsu T, Kudo T, Miura F, Nishiya I (1995) Numerical and structural chromosome abnormalities in an ovarian fibrothecoma. Cancer Genet Cytogenet 83:84–86PubMedCrossRef Izutsu T, Kudo T, Miura F, Nishiya I (1995) Numerical and structural chromosome abnormalities in an ovarian fibrothecoma. Cancer Genet Cytogenet 83:84–86PubMedCrossRef
8.
Zurück zum Zitat Jenkins RB, Bartelt D Jr., Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76–86PubMedCrossRef Jenkins RB, Bartelt D Jr., Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76–86PubMedCrossRef
9.
Zurück zum Zitat Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821PubMedCrossRef Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821PubMedCrossRef
10.
Zurück zum Zitat Knuutila S, Nylund SJ, Wessman M, Larramendy ML (1994) Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology. Cancer Genet Cytogenet 72:1–15PubMedCrossRef Knuutila S, Nylund SJ, Wessman M, Larramendy ML (1994) Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology. Cancer Genet Cytogenet 72:1–15PubMedCrossRef
11.
Zurück zum Zitat Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Trope CG, Danielsen HE (2003) Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14:1494–1500PubMedCrossRef Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Trope CG, Danielsen HE (2003) Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14:1494–1500PubMedCrossRef
12.
Zurück zum Zitat Kurman RJ (ed) (2002) Blaustein’s pathology of the female genital tract. Springer-Verlag, New York Kurman RJ (ed) (2002) Blaustein’s pathology of the female genital tract. Springer-Verlag, New York
13.
Zurück zum Zitat Leung WY, Schwartz PE, Ng HT, Yang-Feng TL (1990) Trisomy 12 in benign fibroma and granulosa cell tumor of the ovary. Gynecol Oncol 38:28–31PubMedCrossRef Leung WY, Schwartz PE, Ng HT, Yang-Feng TL (1990) Trisomy 12 in benign fibroma and granulosa cell tumor of the ovary. Gynecol Oncol 38:28–31PubMedCrossRef
14.
Zurück zum Zitat Liang SB, Sonobe H, Taguchi T, Takeuchi T, Furihata M, Yuri K, Ohtsuki Y (2001) Tetrasomy 12 in ovarian tumors of thecoma–fibroma group: a fluorescence in situ hybridization analysis using paraffin sections. Pathol Int 51:37–42PubMedCrossRef Liang SB, Sonobe H, Taguchi T, Takeuchi T, Furihata M, Yuri K, Ohtsuki Y (2001) Tetrasomy 12 in ovarian tumors of thecoma–fibroma group: a fluorescence in situ hybridization analysis using paraffin sections. Pathol Int 51:37–42PubMedCrossRef
15.
Zurück zum Zitat Liehr T, Grehl H, Rautenstrauss B (1995) FISH analysis of interphase nuclei extracted from paraffin-embedded tissue. Trends Genet 11:377–378PubMedCrossRef Liehr T, Grehl H, Rautenstrauss B (1995) FISH analysis of interphase nuclei extracted from paraffin-embedded tissue. Trends Genet 11:377–378PubMedCrossRef
16.
Zurück zum Zitat Mandahl N (2001) Methods in solid tumors cytogenetics. In: Rooney DE (ed) Human cytogenetics—malignancy and acquired abnormalities. Oxford University Press, Oxford, pp 165–203 Mandahl N (2001) Methods in solid tumors cytogenetics. In: Rooney DE (ed) Human cytogenetics—malignancy and acquired abnormalities. Oxford University Press, Oxford, pp 165–203
17.
Zurück zum Zitat Micci F, Teixeira MR, Haugom L, Kristensen G, Abeler VM, Heim S (2004) Genomic aberrations in carcinomas of the uterine corpus. Genes Chromosomes Cancer 40:229–246PubMedCrossRef Micci F, Teixeira MR, Haugom L, Kristensen G, Abeler VM, Heim S (2004) Genomic aberrations in carcinomas of the uterine corpus. Genes Chromosomes Cancer 40:229–246PubMedCrossRef
19.
Zurück zum Zitat Mrozek K, Limon J, Debniak J, Emerich J (1992) Trisomy 12 and 4 in a thecoma of the ovary. Gynecol Oncol 45:66–68PubMedCrossRef Mrozek K, Limon J, Debniak J, Emerich J (1992) Trisomy 12 and 4 in a thecoma of the ovary. Gynecol Oncol 45:66–68PubMedCrossRef
20.
Zurück zum Zitat Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F (1990) Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 85:605–611PubMedCrossRef Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F (1990) Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 85:605–611PubMedCrossRef
21.
Zurück zum Zitat Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F (1990) Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet Cytogenet 45:63–66PubMedCrossRef Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F (1990) Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet Cytogenet 45:63–66PubMedCrossRef
23.
Zurück zum Zitat Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F (1990) Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chromosomes Cancer 2:48–52PubMedCrossRef Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F (1990) Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chromosomes Cancer 2:48–52PubMedCrossRef
24.
Zurück zum Zitat Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB (1993) Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733–741PubMed Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB (1993) Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733–741PubMed
25.
Zurück zum Zitat Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB (1994) Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102:775–779PubMed Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB (1994) Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102:775–779PubMed
26.
Zurück zum Zitat Shashi V, Golden WL, Kap-Herr C, Andersen WA, Gaffey MJ (1994) Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 55:349–354PubMedCrossRef Shashi V, Golden WL, Kap-Herr C, Andersen WA, Gaffey MJ (1994) Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 55:349–354PubMedCrossRef
27.
Zurück zum Zitat Smith LM, Hu P, Meyer LJ, Coffin CM (2002) Complex karyotypic abnormality in ovarian fibroma associated with Gorlin syndrome. Am J Med Genet 112:61–64PubMedCrossRef Smith LM, Hu P, Meyer LJ, Coffin CM (2002) Complex karyotypic abnormality in ovarian fibroma associated with Gorlin syndrome. Am J Med Genet 112:61–64PubMedCrossRef
28.
Zurück zum Zitat Taruscio D, Carcangiu ML, Ward DC (1993) Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagn Mol Pathol 2:94–98PubMed Taruscio D, Carcangiu ML, Ward DC (1993) Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagn Mol Pathol 2:94–98PubMed
29.
Zurück zum Zitat Tavassoli FA, Devilee P (eds) (2003) World health organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs. IARC, Lyon Tavassoli FA, Devilee P (eds) (2003) World health organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs. IARC, Lyon
30.
Zurück zum Zitat Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS (1994) Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer 10:262–266PubMedCrossRef Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS (1994) Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer 10:262–266PubMedCrossRef
Metadaten
Titel
Consistent numerical chromosome aberrations in thecofibromas of the ovary
verfasst von
Francesca Micci
Lisbeth Haugom
Vera M. Abeler
Claes G. Tropé
Håvard E. Danielsen
Sverre Heim
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 3/2008
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0561-x

Weitere Artikel der Ausgabe 3/2008

Virchows Archiv 3/2008 Zur Ausgabe

Letter to the Editor

Adenohibernoma of the breast

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …